Holen Sie sich die Stockscreener-App
6.10
2.16%
0.18
Schlusskurs vom Vortag:
$5.92
Offen:
$6
24-Stunden-Volumen:
76,134
Relative Volume:
0.84
Marktkapitalisierung:
$71.23M
Einnahmen:
$200.00K
Nettoeinkommen (Verlust:
$-26.17M
KGV:
-2.3483
EPS:
-2.5976
Netto-Cashflow:
$-18.64M
1W Leistung:
+12.94%
1M Leistung:
+42.97%
6M Leistung:
+4.27%
1J Leistung:
+38.39%
1-Tages-Spanne:
$5.92
$6.525
1-Wochen-Bereich:
$5.18
$6.525
52-Wochen-Spanne:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.0478 | 69.73M | 200.00K | -26.17M | -18.64M | -2.5976 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.15 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.29 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.29 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.81 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.42 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
Clene (CLNN) Analyst Rating Maintained at "Buy" with $23 Target - GuruFocus
Clene Nanomedicine "CNM-Au8" Market size expansion of Several Folds by 2034 - openPR.com
Clene (CLNN) Reports FY25 Revenue Beat and Prepares for Key FDA Meeting - GuruFocus
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - Investing News Network
Biopharmaceutical company Clene Inc (CLNN) recently unveiled its new financing strategy—two potential additional financings totaling over $22 millions have completed structural design. This funding plan will enable the company’s operational cash flow to la - Bitget
Clene reports full-year 2025 results: $200k revenue, $26.2M net loss - TradingView
ALS drug CNM-Au8 links biomarker declines to survival, Clene plans FDA filing - Stock Titan
Top Nanotechnology Stocks To Keep An Eye OnMarch 11th - MarketBeat
Nanotechnology Stocks To ConsiderMarch 10th - MarketBeat
Nanotechnology Stocks To Watch TodayMarch 9th - MarketBeat
Published on: 2026-03-09 03:28:27 - baoquankhu1.vn
Best Nanotechnology Stocks To ResearchMarch 8th - MarketBeat
Aug Selloffs: What are the analyst revisions for INCYIs Clene Inc. stock a good investment in YEARNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Movers: Should I set a stop loss on Clene IncExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Top Nanotechnology Stocks To ResearchMarch 6th - MarketBeat
Institution Moves: How do insiders feel about Clene IncQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Nanotechnology Stocks To Follow TodayMarch 5th - MarketBeat
Best Nanotechnology Stocks Worth Watching – March 3rd - Defense World
Nanotechnology Stocks To Follow NowMarch 4th - MarketBeat
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Nanotechnology Stocks To Follow Today – March 2nd - Defense World
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Top Nanotechnology Stocks To Consider – March 1st - Defense World
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Top Nanotechnology Stocks To ConsiderMarch 1st - MarketBeat
Update Recap: Is Clene Inc a play on infrastructure spendingJuly 2025 Retail & Stock Portfolio Risk Management - baoquankhu1.vn
Top Nanotechnology Stocks To Follow TodayFebruary 28th - MarketBeat
CLNN Should I Buy - Intellectia AI
Best Nanotechnology Stocks To Follow NowFebruary 27th - MarketBeat
Aug Swings: Is LXRX gaining market sharePortfolio Value Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway - MarketBeat
CLNN: Strong biomarker and survival data for ALS therapy positions company for NDA filing and 2027 launch - TradingView
CLNN: Strong biomarker and survival data support accelerated ALS approval, with NDA filing by Q2 - TradingView
CLNN SEC FilingsClene 10-K, 10-Q, 8-K Forms - Stock Titan
Risks Report: What is the Moat Score of Clene IncJuly 2025 Chart Watch & Growth Focused Stock Reports - baoquankhu1.vn
Nanotechnology Stocks To Watch NowFebruary 24th - MarketBeat
Growth Recap: What chart patterns are forming on Clene Inc Equity WarrantWeekly Trade Analysis & AI Enhanced Execution Alerts - baoquankhu1.vn
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts - Investing News Network
Clene outlines 2026 regulatory milestones and ALS strategy - TipRanks
Clene (CLNN) Outlines Key Developments for CNM-Au8 in 2026 - GuruFocus
Clene Inc. Outlines Key Milestones for 2026 - Intellectia AI
Experimental ALS drug CNM-Au8 heads toward 2026 FDA review - Stock Titan
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream - Investing News Network
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8 2026 Catalysts - Bitget
Nanotechnology Stocks Worth WatchingFebruary 23rd - MarketBeat
Chart Watch: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAREarnings Recap Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Clene (CLNN) director awarded 4,098 stock options in Form 4 filing - Stock Titan
Published on: 2026-02-20 10:15:16 - baoquankhu1.vn
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks Worth Watching – February 16th - Defense World
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):